Philippe Martin
Chief Tech/Sci/R&D Officer chez VIATRIS INC.
Profil
Philippe Martin is currently the Chief Research & Development Officer at Viatris, Inc. He previously worked as the VP Project Leadership & Project Management at Celgene Corp from 2009 to 2016 and as the Chief Clinical Development & Operations Officer at BioAtla, Inc. from 2018 to 2023.
Mr. Martin holds an MBA from EM Lyon Business School.
Postes actifs de Philippe Martin
| Sociétés | Poste | Début |
|---|---|---|
| VIATRIS INC. | Chief Tech/Sci/R&D Officer | 15/12/2023 |
Anciens postes connus de Philippe Martin
| Sociétés | Poste | Fin |
|---|---|---|
| BIOATLA, INC. | Chief Operating Officer | 01/09/2023 |
| CELGENE | Corporate Officer/Principal | 04/06/2016 |
Formation de Philippe Martin
| EM Lyon Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOATLA, INC. | Health Technology |
| VIATRIS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
